NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Molina, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/molina-healthcare-inc-class-action. Investors have until December 2, 2025, to ask the Court to be appoin ...

文章核心观点 - 霍华德·G·史密斯律师事务所宣布，已代表Fortinet Inc、Molina Healthcare Inc和Marex Group plc三家上市公司的股东提起集体诉讼，并公布了各类诉讼的集体诉讼期和首席原告截止日期 [1][2][3][4] Fortinet Inc (FTNT) 诉讼要点 - 集体诉讼期为2024年11月8日至2025年8月6日，首席原告截止日期为2025年11月21日 [2] - 指控称公司在集体诉讼期内作出了虚假和/或误导性陈述，未能披露：产品更新周期并不像其宣称的那样有利可图，因其仅由占公司业务"很小百分比"的旧产品构成 [2] - 指控公司对其可升级的FortiGate防火墙真实数量缺乏清晰了解，且隐瞒了其在2025年第二季度末的几个月内激进地完成了约一半的更新，却向投资者表示更新将在两年内逐步获得动力 [2] Molina Healthcare Inc (MOH) 诉讼要点 - 集体诉讼期为2025年2月5日至2025年7月23日，首席原告截止日期为2025年12月2日 [3] - 指控称公司在集体诉讼期内未能披露：有关公司"医疗成本趋势假设"的重大不利事实，以及公司正经历"保费费率与医疗成本趋势之间的错配" [3] - 指控公司隐瞒了其短期增长依赖于行为健康、药房及住院和门诊服务"使用率"的缺乏，且因此其2025财年财务指引极有可能被大幅下调 [3] Marex Group plc (MRX) 诉讼要点 - 集体诉讼期为2024年5月16日至2025年8月5日，首席原告截止日期为2025年12月8日 [4] - 指控称公司在集体诉讼期内未能披露：公司向自身出售了场外金融工具，且其子公司与关联方之间的财务报表存在不一致，涉及公司间应收款和贷款 [4] - 指控因此公司的财务报表不可信赖，其关于业务、运营和前景的正面陈述存在重大误导性或缺乏合理依据 [4]

The upcoming report from Molina (MOH) is expected to reveal quarterly earnings of $3.97 per share, indicating a decline of 33.9% compared to the year-ago period. Analysts forecast revenues of $10.9 billion, representing an increase of 5.4% year over year.The consensus EPS estimate for the quarter has undergone an upward revision of 7.8% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.A ...

SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), have until Tuesday, December 2, 2025 to seek appointment as lead plaintiff of the Molina class action lawsuit. Captioned Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461 (C.D. Cal.), the Molina Healthcare class action lawsuit charges Mo ...

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Molina and certain of its o ...

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Molina, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/molina-healthcare-inc-class-action. Investors have until December 2, 2025, to ask the Court to be appoin ...

诉讼背景 - 知名证券律师事务所Bleichmar Fonti & Auld LLP宣布对Molina Healthcare Inc及其部分高级执行官提起集体诉讼 指控其可能违反联邦证券法 [1] - 诉讼代表在特定期间内投资Molina证券的投资者提出 依据1934年证券交易法第10(b)条和第20(a)条 [2] - 案件在美国加州中区联邦地区法院审理 案件编号为Hindlemann v Molina Healthcare Inc et al No 25-cv-9461 [2] 指控核心 - 公司曾向投资者表示其盈利增长前景稳健 并声称持续监控医疗资源使用模式 能够缓解医疗成本通胀的负面影响 [3] - 指控称 Molina实际上在所有三条业务线中都面临医疗使用量增加带来的成本压力 且无法有效缓解这些压力 [3] 财务表现与股价影响 - 2025年7月7日 公司披露第二季度调整后每股收益约为5.50美元 低于此前预期 原因在于所有业务线均面临医疗成本压力 [4] - 公司将全年调整后每股收益指引中点下调10.2% 至21.50美元至22.50美元的区间 [4] - 2025年7月23日 公司进一步将全年调整后每股收益预期下调至不低于19.00美元 归因于行为健康、药房及住院和门诊服务使用量增加带来的挑战性医疗成本趋势 [4] - 受此消息影响 公司股价从2025年7月23日的每股190.25美元下跌32.03美元（跌幅16.8%）至2025年7月24日的每股158.22美元 [4]

Molina Healthcare (NYSE: MOH ) is currently being heavily penalized by a perceived reduction in profitability due to higher utilization costs in the managed healthcare industry. We believe that new rates for Medicaid andAnalyst’s Disclosure:I/we have a beneficial long position in the shares of MOH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no busin ...

公司股价表现 - Molina Healthcare (NYSE: MOH) 股价目前因市场对其盈利能力下降的预期而受到严重打压 [1] 行业与公司盈利压力 - 盈利压力主要源于管理医疗保健行业不断上升的使用成本 [1] - 医疗补助计划的新费率被视为解决当前盈利压力的潜在积极因素 [1]

诉讼基本信息 - 律师事务所Kessler Topaz Meltzer & Check, LLP宣布对Molina Healthcare, Inc (NYSE: MOH)提起证券集体诉讼 [1] - 诉讼代表在2025年2月5日至2025年7月23日期间购买或收购Molina证券的投资者 [1] - 首席原告截止日期为2025年12月2日 [1][3] 指控内容 - 指控被告在集体诉讼期间作出虚假和/或误导性陈述，未能披露有关公司医疗成本趋势假设的重大不利事实 [2] - 指控Molina正经历保费费率与医疗成本趋势之间的脱节 [2] - 指控Molina的短期增长依赖于行为健康、药房以及住院和门诊服务利用率不足的情况 [2] - 指控因此Molina对2025财年的财务指引极有可能被大幅下调 [2] - 指控被告关于公司业务、运营和前景的正面陈述因此具有重大误导性且缺乏合理依据 [2]